TLK2 Enhances Aggressive Phenotypes of Glioblastoma Cells Through the Activation of SRC Signaling Pathway

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2018.1507257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited